Scotland: Hope for patients with pulmonary fibrosis
The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…
The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than…
This website uses cookies.